Novo Nordisk A/S (NVO) Balance Sheet

NYSE: NVOAssets, liabilities, debt and equity over 10 years.

NVO balance sheet, 2025

December 31, 2025 · Danish kroner

DKK 542.90B assets = DKK 348.86B liabilities + DKK 194.05B equity

What it ownsDKK 542.90BCash & ST investments: DKK 26.96B (5.0%)Receivables: DKK 75.70B (13.9%)ReceivablesDKK 75.70B · 14%Inventory: DKK 49.62B (9.1%)Inventory DKK 49.62BOther current: DKK 20.17B (3.7%)PP&E: DKK 208.38B (38.4%)PP&EDKK 208.38B · 38%Goodwill & intangibles: DKK 130.05B (24.0%)Goodwill & intangiblesDKK 130.05B · 24%LT investments: DKK 2.51B (0.5%)Other non-current: DKK 29.51B (5.4%)=How it is financedDKK 542.90BCurrent liabilities: DKK 215.66B (39.7%)Current liabilitiesDKK 215.66B · 40%Long-term debt: DKK 118.94B (21.9%)Long-term debtDKK 118.94B · 22%Other LT liabilities: DKK 14.25B (2.6%)Shareholders’ equity: DKK 194.05B (35.7%)Shareholders’ equityDKK 194.05B · 36%

Both columns are drawn to the same scale: what NVO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

NVO financial health

Current ratio0.80
Tight · current assets cover current liabilities 0.80×
Debt / equity0.67
Moderate leverage · DKK 0.67 of debt for each $1 of equity
Equity / assets35.7%
Balanced · of assets funded by shareholders
Cash / debt20.6%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles24.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

NVO balance sheet trends, 2016–2025

Novo Nordisk A/S balance sheet trends
MetricTrendThenLatestChange
Total assetsDKK 97.54B2016DKK 542.90B2025+21.0%/yr
Total liabilitiesDKK 52.27B2016DKK 348.86B2025+23.5%/yr
Shareholders’ equityDKK 45.27B2016DKK 194.05B2025+17.6%/yr
Cash & short-term investmentsDKK 20.70B2016DKK 26.96B2025+3.0%/yr
Total debtDKK 229.0M2016DKK 130.96B2025+102.5%/yr
Net cash (debt)DKK 20.47B2016−DKK 104.00B2025DKK 124.5B
Working capitalDKK 12.33B2016−DKK 43.21B2025DKK 55.5B
Current ratio1.2620160.802025−0.46
Debt / equity0.0120160.672025+0.67
Shares outstanding5.07B20164.45B2025−1.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

NVO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

NVO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

NVO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

NVO balance sheet in Danish kroner

Novo Nordisk A/S annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investmentsDKK 26.96BDKK 26.31BDKK 30.23BDKK 23.57BDKK 17.48BDKK 12.76BDKK 15.47BDKK 15.64BDKK 18.85BDKK 20.70B
Cash & equivalentsDKK 26.46BDKK 15.65BDKK 14.39BDKK 12.65BDKK 10.72BDKK 12.76BDKK 15.47BDKK 15.64BDKK 18.85BDKK 18.69B
Short-term investmentsDKK 498.0MDKK 10.65BDKK 15.84BDKK 10.92BDKK 6.76BDKK 0DKK 0DKK 0DKK 2.30BDKK 2.01B
ReceivablesDKK 75.70BDKK 87.41BDKK 75.26BDKK 57.51BDKK 46.80BDKK 32.18BDKK 29.15BDKK 26.89BDKK 23.55BDKK 24.20B
InventoryDKK 49.62BDKK 40.85BDKK 31.81BDKK 24.39BDKK 19.62BDKK 18.54BDKK 17.64BDKK 16.34BDKK 15.37BDKK 14.34B
Other current assetsDKK 20.17BDKK 6.33BDKK 2.34BDKK 2.73BDKK 1.69BDKK 2.33BDKK 188.0MDKK 204.0MDKK 2.30BDKK 529.0M
Total current assetsDKK 172.45BDKK 160.90BDKK 139.65BDKK 108.19BDKK 85.59BDKK 65.81BDKK 62.46BDKK 59.07BDKK 60.08BDKK 59.77B
Property, plant & equipment (net)DKK 208.38BDKK 162.49BDKK 90.96BDKK 66.67BDKK 55.36BDKK 50.27BDKK 50.55BDKK 41.89BDKK 35.25BDKK 30.18B
Goodwill & intangible assetsDKK 130.05BDKK 111.09BDKK 60.41BDKK 51.42BDKK 43.17BDKK 20.66BDKK 5.83BDKK 5.14BDKK 3.33BDKK 2.71B
Long-term investmentsDKK 2.51BDKK 2.68BDKK 1.66BDKK 1.34BDKK 1.44BDKK 1.65BDKK 1.81BDKK 1.77BDKK 1.76BDKK 2.20B
Other non-current assetsDKK 29.51BDKK 28.64BDKK 21.81BDKK 13.63BDKK 8.94BDKK 6.54BDKK 4.96BDKK 2.89BDKK 1.94BDKK 2.68B
Total assetsDKK 542.90BDKK 465.80BDKK 314.49BDKK 241.26BDKK 194.51BDKK 144.92BDKK 125.61BDKK 110.77BDKK 102.36BDKK 97.54B
Liabilities
Accounts payableDKK 19.76BDKK 28.85BDKK 25.61BDKK 15.59BDKK 8.87BDKK 5.72BDKK 6.36BDKK 6.76BDKK 5.61BDKK 6.01B
Short-term debtDKK 12.02BDKK 13.11BDKK 6.48BDKK 1.47BDKK 13.68BDKK 7.46BDKK 1.47BDKK 515.0MDKK 1.69BDKK 229.0M
Deferred revenue——DKK 107.59B—DKK 55.18BDKK 38.73BDKK 35.33BDKK 44.87BDKK 39.44BDKK 38.62B
Total current liabilitiesDKK 215.66BDKK 217.53BDKK 169.66BDKK 120.94BDKK 99.52BDKK 70.27BDKK 58.98BDKK 54.16BDKK 47.06BDKK 47.44B
Long-term debtDKK 118.94BDKK 89.67BDKK 20.53BDKK 24.32BDKK 12.96BDKK 2.90BDKK 3.01BDKK 0DKK 0DKK 0
Lease obligationsDKK 8.57BDKK 6.77BDKK 5.73BDKK 4.53BDKK 4.13BDKK 3.67BDKK 3.82BDKK 0DKK 0DKK 0
Other long-term liabilitiesDKK 14.25BDKK 15.11BDKK 17.74BDKK 12.51BDKK 11.29BDKK 8.43BDKK 6.03BDKK 4.77BDKK 5.48BDKK 4.83B
Total liabilitiesDKK 348.86BDKK 322.31BDKK 207.93BDKK 157.77BDKK 123.76BDKK 81.60BDKK 68.02BDKK 58.93BDKK 52.54BDKK 52.27B
Shareholders' equity
Common stock & paid-in capitalDKK 446.0MDKK 446.0MDKK 451.0MDKK 456.0MDKK 462.0MDKK 470.0MDKK 480.0MDKK 490.0MDKK 500.0MDKK 510.0M
Retained earnings (deficit)DKK 195.30BDKK 144.45BDKK 104.84BDKK 80.59BDKK 72.00BDKK 63.77BDKK 57.82BDKK 53.41BDKK 48.98BDKK 46.11B
Treasury stock————−DKK 6.0M−DKK 8.0M−DKK 10.0M−DKK 11.0M−DKK 11.0M−DKK 9.0M
Accumulated other comprehensive income−DKK 1.70B−DKK 1.41BDKK 1.28BDKK 2.45B−DKK 1.71B−DKK 911.0M−DKK 694.0M−DKK 2.05BDKK 349.0M−DKK 1.34B
Minority interest——————DKK 0DKK 0DKK 0DKK 0
Total shareholders' equityDKK 194.05BDKK 143.49BDKK 106.56BDKK 83.49BDKK 70.75BDKK 63.33BDKK 57.59BDKK 51.84BDKK 49.81BDKK 45.27B
Key figures
Total debtDKK 130.96BDKK 102.79BDKK 27.01BDKK 25.78BDKK 26.64BDKK 10.36BDKK 4.48BDKK 515.0MDKK 1.69BDKK 229.0M
Net cash (debt)−DKK 104.00B−DKK 76.48BDKK 3.22B−DKK 2.21B−DKK 9.16BDKK 2.40BDKK 10.99BDKK 15.12BDKK 17.16BDKK 20.47B
Working capital−DKK 43.21B−DKK 56.63B−DKK 30.01B−DKK 12.75B−DKK 13.92B−DKK 4.46BDKK 3.47BDKK 4.90BDKK 13.02BDKK 12.33B
Tangible book valueDKK 63.99BDKK 32.40BDKK 46.16BDKK 32.07BDKK 27.57BDKK 42.67BDKK 51.76BDKK 46.69BDKK 46.49BDKK 42.55B
Shares outstanding4.45B4.46B4.49B4.54B4.61B4.68B4.76B4.85B4.96B5.07B
Current ratio0.800.740.820.890.860.941.061.091.281.26
Quick ratio0.480.520.620.670.650.640.760.790.900.95
Debt / equity0.670.720.250.310.380.160.080.010.030.01
Equity / assets35.7%30.8%33.9%34.6%36.4%43.7%45.8%46.8%48.7%46.4%

Quarterly columns are labeled by the month the quarter ended. Figures in Danish kroner as reported (latest annual report filed February 4, 2026); data from EODHD.

NVO financial position

At the end of fiscal 2025 (December 31, 2025), Novo Nordisk A/S had total assets of DKK 542.9 billion (up 16.6% from a year earlier), total liabilities of DKK 348.9 billion and shareholders' equity of DKK 194.0 billion. It held DKK 27.0 billion in cash and short-term investments against DKK 131.0 billion of debt, net debt of DKK 104.0 billion. Its current ratio was 0.80. In the latest quarter (ended June 30, 2026) total assets were DKK 594.9 billion and equity DKK 221.3 billion.

Related: NVO income statement, NVO cash flow statement, NVO key metrics. See the NVO stock overview for the latest quote and news.

NVO balance sheet FAQ

What are Novo Nordisk A/S's total assets?

Novo Nordisk A/S reported total assets of DKK 542.9 billion at the end of fiscal 2025 (December 31, 2025), compared with DKK 465.8 billion a year earlier.

How much debt does Novo Nordisk A/S have?

Novo Nordisk A/S had DKK 131.0 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.67.

How much cash does Novo Nordisk A/S have?

Novo Nordisk A/S held DKK 27.0 billion in cash and short-term investments at the end of fiscal 2025; with DKK 131.0 billion of debt that is net debt of DKK 104.0 billion.

What is Novo Nordisk A/S's book value?

Novo Nordisk A/S's shareholders' equity (book value) was DKK 194.0 billion at the end of fiscal 2025.

What is Novo Nordisk A/S's current ratio?

Novo Nordisk A/S had current assets of DKK 172.5 billion and current liabilities of DKK 215.7 billion, a current ratio of 0.80 (current liabilities exceed current assets).

How much goodwill does Novo Nordisk A/S have?

Novo Nordisk A/S carried DKK 130.1 billion of goodwill and intangible assets, 24.0% of total assets, at the end of fiscal 2025.

Drug Manufacturers - General: balance sheet